Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)Active Not RecruitingNCT04143607What this trial is testingASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLCWho this might be right forLocally Advanced or Metastatic NSCLC Jiangsu Aosaikang Pharmaceutical Co., Ltd. 337
Testing effectiveness (Phase 2)Study completedNCT00139711What this trial is testingThree Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 138
Testing effectiveness (Phase 2)Study completedNCT01243775What this trial is testingBELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLCWho this might be right forNon-Small Cell Lung Cancer Chonnam National University Hospital 33
Not applicableStudy completedNCT00823732What this trial is testingEffects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryWho this might be right forLung Cancer City of Hope Medical Center 280
Large-scale testing (Phase 3)Ended earlyNCT02129699What this trial is testingSurvival imProvement in Lung cancEr iNduced by DenOsUmab theRapyWho this might be right forLung Cancer Non-small Cell Stage IV ETOP IBCSG Partners Foundation 595
Large-scale testing (Phase 3)UnknownNCT00955695What this trial is testingRadiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer National Cancer Center, Korea 242
Testing effectiveness (Phase 2)UnknownNCT00908336What this trial is testingErlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy RegimenWho this might be right forNon-Small Cell Lung Cancer Hospital Arnau de Vilanova 70
Testing effectiveness (Phase 2)Study completedNCT03595644What this trial is testingMaintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung CancerWho this might be right forStage IV Non-small Cell Lung Cancer Tongji Hospital 74
Not applicableStudy completedNCT02910999What this trial is testingReal-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior ChemotherapyWho this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 868
Testing effectiveness (Phase 2)Ended earlyNCT01337154What this trial is testingFirst Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung CancerWho this might be right forStage IIIB Non-small Cell Lung Cancer With Pleural EffusionStage IV Non-small Cell Lung Cancer CytRx 140
Large-scale testing (Phase 3)Ended earlyNCT02162537What this trial is testingTherapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain MetastasesWho this might be right forNon-small Cell Lung Cancer MetastaticNon-small Cell Lung CancerAdenocarcinoma of Lung Metastatic to Brain+1 more Centre Hospitalier Intercommunal Creteil 95
Not applicableUnknownNCT01493011What this trial is testingChemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Stage IIIBToxicity Due to Chemotherapy Xijing Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03526900What this trial is testingAtezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain MetastasisWho this might be right forNon-small Cell Lung Cancer Stage IV Spanish Lung Cancer Group 40
Not applicableStudy completedNCT03959137What this trial is testingBEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in BelgiumWho this might be right forStage IV Non-small Cell Lung Cancer MSD Belgium BVBA 215
Early research (Phase 1)Ended earlyNCT00901537What this trial is testingAzacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck CancerWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck Loma Linda University 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03778229What this trial is testingOsimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior OsimertinibWho this might be right forCarcinoma AstraZeneca 367
Large-scale testing (Phase 3)Study completedNCT02027428What this trial is testingSafety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerWho this might be right forSquamous Cell Carcinoma, Non-Small-Cell Lung Celgene 427
Not applicableStudy completedNCT00900328What this trial is testingStudy of Tumor Samples From Patients With Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 280
Testing effectiveness (Phase 2)UnknownNCT04878107What this trial is testingSBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and ChemotherapyWho this might be right forNon-Small Cell Lung Cancer Wuhan University 88